U.S. Metagenomics Market Size & Outlook, 2023-2030
U.S. metagenomics market, 2018-2030 (US$M)
Related Markets
U.S. metagenomics market highlights
- The U.S. metagenomics market generated a revenue of USD 776.5 million in 2023 and is expected to reach USD 1,791.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12.7% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 776.5 million |
| Market revenue in 2030 | USD 1,791.3 million |
| Growth rate | 12.7% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.3% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,791.3 million by 2030.
Kits & reagents was the largest segment with a revenue share of 61.51% in 2023. Horizon Databook has segmented the U.S. metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. dominated North America’s market due to its extensive genomics, oncology, and wholegenome sequencing research. Other factors attributed to the significant adoption of metagenomics technology in this country are sophisticated research & medical infrastructure, funding, skilled personnel, and companies pushing for better research methods to identify newer technologies for diagnosis & therapies.
The U.S. is witnessing rapid clinical developments in NGS methodologies for applications in oncology and infectious diseases. The presence of market leaders, such as Illumina, Roche, and Life Technologies, which are involved in developing rapid and high-throughput sequencing capabilities, has contributed to the country’s market growth. These players are undertaking several strategic initiatives to strengthen their market presence in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. metagenomics market size, by product, 2018-2030 (US$M)
U.S. Metagenomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
